Release 4 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see times).
See the Directory of published versions icon . Page versions: R5 R4B R4 R3 R2

Using Codes Code Systems Value Sets Concept Maps Identifier Systems

4.4.1.234 4.4.1.255 Value Set ValueSet http://hl7.org/fhir/ValueSet/vaccine-code

  Maturity Level : 1
Responsible Owner: Public Health and Emergency Response icon Work Group Draft Use Context : Any Country: World
This is a value set defined by the FHIR project. Summary Committee:
Official URL : Title: http://hl7.org/fhir/ValueSet/vaccine-code Vaccine Administered Value Set Definition: This identifies the vaccine substance administered - CVX codes. Version : 6.0.0-ballot3
active as of 2025-11-10 Public Health and Emergency Response Computable Name : VaccineAdministeredValueSet Work Group
OID: Flags : 2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems) Source Resource XML / JSON : 2.16.840.1.113883.3.88.12.80.22

This value set is used in the following places:

  • Resource: ImmunizationRecommendation.recommendation.vaccineCode (CodeableConcept / Example ) Resource: ImmunizationRecommendation.recommendation.contraindicatedVaccineCode (CodeableConcept / Example ) Resource: Immunization.vaccineCode (CodeableConcept / Example )

4.4.1.234.1 4.4.1.255.1 Definition

This identifies the vaccine substance administered - CVX codes.

4.4.1.255.2 Content Logical Definition

Generated Narrative: ValueSet vaccine-code

Last updated: 2025-11-10T04:50:58.407Z

This value set includes codes from based on the following code systems: rules:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx icon version Not Stated (use latest from terminology server)
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17 version Not Stated (use latest from terminology server)

 

4.4.1.234.2 4.4.1.255.3 Expansion

This expansion generated 01 10 Nov 2019 2025

ValueSet

Expansion from tx.fhir.org based on codesystem Vaccine Administered Code Set (CVX) version 20250715

This value set contains 268 360 concepts

System Code System Display Display (English)
143 http://hl7.org/fhir/sid/cvx   01 DTP diphtheria, tetanus toxoids and pertussis vaccine
http://hl7.org/fhir/sid/cvx   02 OPV, trivalent trivalent poliovirus vaccine, live, oral
Adenovirus types 4 http://hl7.org/fhir/sid/cvx   03 MMR measles, mumps and 7 rubella virus vaccine
54 http://hl7.org/fhir/sid/cvx   04 M/R measles and rubella virus vaccine
http://hl7.org/fhir/sid/cvx   05 adenovirus, type 4 measles measles virus vaccine
55 http://hl7.org/fhir/sid/cvx   06 rubella rubella virus vaccine
http://hl7.org/fhir/sid/cvx   07 adenovirus, type 7 mumps mumps virus vaccine
82 http://hl7.org/fhir/sid/cvx   08 Hep B, adolescent or pediatric hepatitis B vaccine, pediatric or pediatric/adolescent dosage
http://hl7.org/fhir/sid/cvx   09 adenovirus, unspecified formulation Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
24 http://hl7.org/fhir/sid/cvx   10 IPV poliovirus vaccine, inactivated
http://hl7.org/fhir/sid/cvx   11 anthrax pertussis pertussis vaccine
181 http://hl7.org/fhir/sid/cvx   12 diphtheria antitoxin diphtheria antitoxin
http://hl7.org/fhir/sid/cvx   13 anthrax TIG tetanus immune globulin
801 http://hl7.org/fhir/sid/cvx   14 IG, unspecified formulation immune globulin, unspecified formulation
http://hl7.org/fhir/sid/cvx   15 AS03 Adjuvant influenza, split (incl. purified surface antigen) influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
19 http://hl7.org/fhir/sid/cvx   16 influenza, whole influenza virus vaccine, whole virus
http://hl7.org/fhir/sid/cvx   17 BCG Hib, unspecified formulation Haemophilus influenzae type b vaccine, conjugate unspecified formulation
27 http://hl7.org/fhir/sid/cvx   18 rabies, intramuscular injection rabies vaccine, for intramuscular injection RETIRED CODE
http://hl7.org/fhir/sid/cvx   19 botulinum antitoxin BCG Bacillus Calmette-Guerin vaccine
173 http://hl7.org/fhir/sid/cvx   20 DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine
http://hl7.org/fhir/sid/cvx   21 cholera, BivWC varicella varicella virus vaccine
174 http://hl7.org/fhir/sid/cvx   22 DTP-Hib DTP-Haemophilus influenzae type b conjugate vaccine
http://hl7.org/fhir/sid/cvx   23 cholera, live attenuated plague plague vaccine
26 http://hl7.org/fhir/sid/cvx   24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx   25 typhoid, oral typhoid vaccine, live, oral
http://hl7.org/fhir/sid/cvx   26 cholera, unspecified formulation cholera vaccine, unspecified formulation
172 http://hl7.org/fhir/sid/cvx   27 cholera, WC-rBS botulinum antitoxin botulinum antitoxin
29 http://hl7.org/fhir/sid/cvx   28 DT (pediatric) diphtheria and tetanus toxoids, adsorbed for pediatric use
http://hl7.org/fhir/sid/cvx   29 CMVIG cytomegalovirus immune globulin, intravenous
56 http://hl7.org/fhir/sid/cvx   30 HBIG hepatitis B immune globulin
http://hl7.org/fhir/sid/cvx   31 dengue fever Hep A, pediatric, unspecified formulation hepatitis A vaccine, pediatric dosage, unspecified formulation
12 http://hl7.org/fhir/sid/cvx   32 meningococcal MPSV4 meningococcal polysaccharide vaccine (MPSV4)
http://hl7.org/fhir/sid/cvx   33 diphtheria antitoxin pneumococcal polysaccharide PPV23 pneumococcal polysaccharide vaccine, 23 valent
28 http://hl7.org/fhir/sid/cvx   34 RIG rabies immune globulin
http://hl7.org/fhir/sid/cvx   35 DT (pediatric) tetanus toxoid, adsorbed tetanus toxoid, adsorbed
20 http://hl7.org/fhir/sid/cvx   36 VZIG varicella zoster immune globulin
http://hl7.org/fhir/sid/cvx   37 DTaP yellow fever live yellow fever vaccine live
106 http://hl7.org/fhir/sid/cvx   38 rubella/mumps rubella and mumps virus vaccine
http://hl7.org/fhir/sid/cvx   39 Japanese encephalitis SC Japanese Encephalitis Vaccine SC
DTaP, 5 pertussis antigens http://hl7.org/fhir/sid/cvx   40 rabies, intradermal injection rabies vaccine, for intradermal injection
http://hl7.org/fhir/sid/cvx   41 typhoid, parenteral typhoid vaccine, parenteral, other than acetone-killed, dried
http://hl7.org/fhir/sid/cvx   42 Hep B, adolescent/high risk infant hepatitis B vaccine, adolescent/high risk infant dosage
107 http://hl7.org/fhir/sid/cvx   43 Hep B, adult hepatitis B vaccine, adult dosage
http://hl7.org/fhir/sid/cvx   44 Hep B, high-dosage, dialysis or IC Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient
DTaP, http://hl7.org/fhir/sid/cvx   45 Hep B, unspecified formulation hepatitis B vaccine, unspecified formulation
146 http://hl7.org/fhir/sid/cvx   46 DTaP,IPV,Hib,HepB Hib (PRP-D) Haemophilus influenzae type b vaccine, PRP-D conjugate
110 http://hl7.org/fhir/sid/cvx   47 Hib (HbOC) Haemophilus influenzae type b vaccine, HbOC conjugate
http://hl7.org/fhir/sid/cvx   48 DTaP-Hep B-IPV Hib (PRP-T) Haemophilus influenzae type b vaccine, PRP-T conjugate
50 http://hl7.org/fhir/sid/cvx   49 Hib (PRP-OMP) Haemophilus influenzae type b vaccine, PRP-OMP conjugate
http://hl7.org/fhir/sid/cvx   50 DTaP-Hib DTaP-Haemophilus influenzae type b conjugate vaccine
120 http://hl7.org/fhir/sid/cvx   51 Hib-Hep B Haemophilus influenzae type b conjugate and Hepatitis B vaccine
http://hl7.org/fhir/sid/cvx   52 DTaP-Hib-IPV Hep A, adult hepatitis A vaccine, adult dosage
130 http://hl7.org/fhir/sid/cvx   53 typhoid, parenteral, AKD (U.S. military) typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
http://hl7.org/fhir/sid/cvx   54 DTaP-IPV adenovirus, type 4 adenovirus vaccine, type 4, live, oral
132 http://hl7.org/fhir/sid/cvx   55 adenovirus, type 7 adenovirus vaccine, type 7, live, oral
http://hl7.org/fhir/sid/cvx   56 DTaP-IPV-HIB-HEP B, historical dengue fever tetravalent dengue fever vaccine, tetravalent
170 http://hl7.org/fhir/sid/cvx   57 hantavirus hantavirus vaccine
http://hl7.org/fhir/sid/cvx   58 DTAP/IPV/HIB - non-US Hep C hepatitis C vaccine
01 http://hl7.org/fhir/sid/cvx   59 Hep E hepatitis E vaccine
http://hl7.org/fhir/sid/cvx   60 DTP herpes simplex 2 herpes simplex virus, type 2 vaccine
22 http://hl7.org/fhir/sid/cvx   61 HIV human immunodeficiency virus vaccine
http://hl7.org/fhir/sid/cvx   62 DTP-Hib HPV, quadrivalent human papilloma virus vaccine, quadrivalent
102 http://hl7.org/fhir/sid/cvx   63 Junin virus Junin virus vaccine
http://hl7.org/fhir/sid/cvx   64 DTP-Hib-Hep B leishmaniasis leishmaniasis vaccine
57 http://hl7.org/fhir/sid/cvx   65 leprosy leprosy vaccine
http://hl7.org/fhir/sid/cvx   66 hantavirus Lyme disease Lyme disease vaccine
30 http://hl7.org/fhir/sid/cvx   67 malaria malaria vaccine
http://hl7.org/fhir/sid/cvx   68 HBIG melanoma melanoma vaccine
52 http://hl7.org/fhir/sid/cvx   69 parainfluenza-3 parainfluenza-3 virus vaccine
http://hl7.org/fhir/sid/cvx   70 Hep A, adult Q fever Q fever vaccine
http://hl7.org/fhir/sid/cvx   71 RSV-IGIV respiratory syncytial virus immune globulin, intravenous
http://hl7.org/fhir/sid/cvx   72 rheumatic fever rheumatic fever vaccine
154 http://hl7.org/fhir/sid/cvx   73 Rift Valley fever Rift Valley fever vaccine
http://hl7.org/fhir/sid/cvx   74 rotavirus, tetravalent rotavirus, live, tetravalent vaccine
Hep A, IG http://hl7.org/fhir/sid/cvx   75 Vaccinia (smallpox, mpox), live Vaccinia (smallpox, mpox) vaccine, live
http://hl7.org/fhir/sid/cvx   76 Staphylococcus bacterio lysate Staphylococcus bacteriophage lysate
http://hl7.org/fhir/sid/cvx   77 Tick-borne encephalitis vaccine (non-US) Tick-borne encephalitis vaccine (non-US)
169 http://hl7.org/fhir/sid/cvx   78 tularemia vaccine tularemia vaccine
http://hl7.org/fhir/sid/cvx   79 vaccinia immune globulin vaccinia immune globulin
Hep A, http://hl7.org/fhir/sid/cvx   80 VEE, live Venezuelan equine encephalitis, live, attenuated
83 http://hl7.org/fhir/sid/cvx   81 VEE, inactivated Venezuelan equine encephalitis, inactivated
http://hl7.org/fhir/sid/cvx   82 adenovirus, unspecified formulation adenovirus vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   83 Hep A, ped/adol, 2 dose hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
84 http://hl7.org/fhir/sid/cvx   84 Hep A, ped/adol, 3 dose hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
31 http://hl7.org/fhir/sid/cvx   85 Hep A, pediatric, unspecified formulation hepatitis A vaccine, unspecified formulation
85 http://hl7.org/fhir/sid/cvx   86 IG immune globulin, intramuscular
http://hl7.org/fhir/sid/cvx   87 IGIV immune globulin, intravenous
Hep A, http://hl7.org/fhir/sid/cvx   88 influenza, unspecified formulation influenza virus vaccine, unspecified formulation
104 http://hl7.org/fhir/sid/cvx   89 Hep A-Hep B polio, unspecified formulation poliovirus vaccine, unspecified formulation
193 http://hl7.org/fhir/sid/cvx   90 Hep A-Hep B, pediatric/adolescent rabies, unspecified formulation rabies vaccine, unspecified formulation
08 http://hl7.org/fhir/sid/cvx   91 Hep B, adolescent or pediatric typhoid, unspecified formulation typhoid vaccine, unspecified formulation
42 http://hl7.org/fhir/sid/cvx   92 Hep B, adolescent/high risk infant VEE, unspecified formulation Venezuelan equine encephalitis vaccine, unspecified formulation
43 http://hl7.org/fhir/sid/cvx   93 RSV-MAb respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
http://hl7.org/fhir/sid/cvx   94 Hep B, adult MMRV measles, mumps, rubella, and varicella virus vaccine
44 http://hl7.org/fhir/sid/cvx   95 TST-OT tine test tuberculin skin test; old tuberculin, multipuncture device
http://hl7.org/fhir/sid/cvx   96 Hep B, dialysis TST-PPD intradermal tuberculin skin test; purified protein derivative solution, intradermal
45 http://hl7.org/fhir/sid/cvx   97 TST-PPD tine test tuberculin skin test; purified protein derivative, multipuncture device
http://hl7.org/fhir/sid/cvx   98 Hep B, TST, unspecified formulation tuberculin skin test; unspecified formulation
58 http://hl7.org/fhir/sid/cvx   99 Hep C RESERVED - do not use RESERVED - do not use
59 http://hl7.org/fhir/sid/cvx   100 Hep E pneumococcal conjugate PCV 7 pneumococcal conjugate vaccine, 7 valent
189 http://hl7.org/fhir/sid/cvx   101 HepB-CpG typhoid, ViCPs typhoid Vi capsular polysaccharide vaccine
60 http://hl7.org/fhir/sid/cvx   102 herpes simplex 2 DTP-Hib-Hep B DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
47 http://hl7.org/fhir/sid/cvx   103 Hib (HbOC) meningococcal C conjugate meningococcal C conjugate vaccine
46 http://hl7.org/fhir/sid/cvx   104 Hib (PRP-D) Hep A-Hep B hepatitis A and hepatitis B vaccine
49 http://hl7.org/fhir/sid/cvx   105 Hib (PRP-OMP) vaccinia (smallpox) diluted vaccinia (smallpox) vaccine, diluted
48 http://hl7.org/fhir/sid/cvx   106 Hib (PRP-T) DTaP, 5 pertussis antigens diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
17 http://hl7.org/fhir/sid/cvx   107 DTaP, unspecified formulation diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   108 Hib, meningococcal ACWY, unspecified formulation meningococcal ACWY vaccine, unspecified formulation
51 http://hl7.org/fhir/sid/cvx   109 pneumococcal, unspecified formulation pneumococcal vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   110 Hib-Hep DTaP-Hep B-IPV DTaP-hepatitis B and poliovirus vaccine
61 http://hl7.org/fhir/sid/cvx   111 Influenza, live, trivalent, intranasal, PF Influenza, live, trivalent, intranasal, preservative free
http://hl7.org/fhir/sid/cvx   112 HIV tetanus toxoid, unspecified formulation tetanus toxoid, unspecified formulation
118 http://hl7.org/fhir/sid/cvx   113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
http://hl7.org/fhir/sid/cvx   114 HPV, bivalent meningococcal MCV4P meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
62 http://hl7.org/fhir/sid/cvx   115 Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
http://hl7.org/fhir/sid/cvx   116 HPV, quadrivalent rotavirus, pentavalent rotavirus, live, pentavalent vaccine
137 http://hl7.org/fhir/sid/cvx   117 VZIG (IND) varicella zoster immune globulin (Investigational New Drug)
http://hl7.org/fhir/sid/cvx   118 HPV, unspecified formulation bivalent human papilloma virus vaccine, bivalent
165 http://hl7.org/fhir/sid/cvx   119 HPV9 rotavirus, monovalent rotavirus, live, monovalent vaccine
86 http://hl7.org/fhir/sid/cvx   120 IG DTaP-Hib-IPV diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
14 http://hl7.org/fhir/sid/cvx   121 zoster live zoster vaccine, live
http://hl7.org/fhir/sid/cvx   122 IG, rotavirus, unspecified formulation rotavirus vaccine, unspecified formulation
87 http://hl7.org/fhir/sid/cvx   123 influenza, H5N1-1203 influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
http://hl7.org/fhir/sid/cvx   125 IGIV Novel Influenza-H1N1-09, nasal Novel Influenza-H1N1-09, live virus for nasal administration
160 http://hl7.org/fhir/sid/cvx   126 Novel influenza-H1N1-09, preservative-free Novel influenza-H1N1-09, preservative-free, injectable
http://hl7.org/fhir/sid/cvx   127 Influenza A monovalent (H5N1), ADJUVANTED-2013 Novel influenza-H1N1-09 Novel influenza-H1N1-09, injectable
151 http://hl7.org/fhir/sid/cvx   128 Novel Influenza-H1N1-09, all formulations Novel influenza-H1N1-09, all formulations
http://hl7.org/fhir/sid/cvx   129 influenza nasal, Japanese Encephalitis, unspecified formulation Japanese Encephalitis vaccine, unspecified formulation
123 http://hl7.org/fhir/sid/cvx   130 DTaP-IPV Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
http://hl7.org/fhir/sid/cvx   131 influenza, H5N1-1203 typhus, historical Historical record of a typhus vaccination
135 http://hl7.org/fhir/sid/cvx   132 DTaP-IPV-HIB-HEP B, historical Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
http://hl7.org/fhir/sid/cvx   133 Influenza, high dose seasonal Pneumococcal conjugate PCV 13 pneumococcal conjugate vaccine, 13 valent
153 http://hl7.org/fhir/sid/cvx   134 Japanese Encephalitis IM Japanese Encephalitis vaccine for intramuscular administration
http://hl7.org/fhir/sid/cvx   135 Influenza, high-dose, trivalent, PF Influenza, high-dose, split virus, trivalent, injectable, MDCK, preservative free
171 http://hl7.org/fhir/sid/cvx   136 Influenza, injectable, MDCK, preservative free, quadrivalent Meningococcal MCV4O meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
186 http://hl7.org/fhir/sid/cvx   137 Influenza, injectable, MDCK, quadrivalent, preservative HPV, unspecified formulation HPV, unspecified formulation
158 http://hl7.org/fhir/sid/cvx   138 influenza, injectable, quadrivalent Td (adult) tetanus and diphtheria toxoids, not adsorbed, for adult use
150 http://hl7.org/fhir/sid/cvx   139 Td(adult) unspecified formulation Td(adult) unspecified formulation
http://hl7.org/fhir/sid/cvx   140 influenza, Influenza, split virus, trivalent, PF Influenza, split virus, trivalent, injectable, quadrivalent, preservative free
161 http://hl7.org/fhir/sid/cvx   141 Influenza, injectable,quadrivalent, split virus, trivalent, preservative Influenza, split virus, trivalent, injectable, contains preservative free, pediatric
166 http://hl7.org/fhir/sid/cvx   142 tetanus toxoid, not adsorbed tetanus toxoid, not adsorbed
http://hl7.org/fhir/sid/cvx   143 Adenovirus types 4 and 7 Adenovirus, type 4 and type 7, live, oral
http://hl7.org/fhir/sid/cvx   144 influenza, seasonal, intradermal, preservative free seasonal influenza, intradermal, quadrivalent, preservative free
111 http://hl7.org/fhir/sid/cvx   145 RSV-MAb (new) respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
http://hl7.org/fhir/sid/cvx   146 influenza, live, intranasal DTaP,IPV,Hib,HepB Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
149 http://hl7.org/fhir/sid/cvx   147 meningococcal MCV4, unspecified formulation Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
http://hl7.org/fhir/sid/cvx   148 influenza, live, intranasal, quadrivalent Meningococcal C/Y-HIB PRP Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
155 http://hl7.org/fhir/sid/cvx   149 Influenza, live, quadrivalent, intranasal Influenza, live, quadrivalent, intranasal
http://hl7.org/fhir/sid/cvx   150 influenza, recombinant, Influenza, split virus, quadrivalent, PF Influenza, split virus, quadrivalent, injectable, preservative free
185 http://hl7.org/fhir/sid/cvx   151 influenza, recombinant, quadrivalent,injectable, preservative free influenza nasal, unspecified formulation influenza nasal, unspecified formulation
141 http://hl7.org/fhir/sid/cvx   152 Influenza, seasonal, injectable Pneumococcal Conjugate, unspecified formulation Pneumococcal Conjugate, unspecified formulation
140 http://hl7.org/fhir/sid/cvx   153 Influenza, seasonal, MDCK, trivalent, PF Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free
144 http://hl7.org/fhir/sid/cvx   154 Hep A, IG Hepatitis A immune globulin
http://hl7.org/fhir/sid/cvx   155 influenza, seasonal, intradermal, Influenza, recombinant, trivalent, PF Influenza, recombinant, trivalent, injectable, preservative free
15 http://hl7.org/fhir/sid/cvx   156 influenza, split (incl. purified surface antigen) Rho(D)-IG Rho(D) Immune globulin- IV or IM
168 http://hl7.org/fhir/sid/cvx   157 influenza, trivalent, adjuvanted Rho(D) -IG IM Rho(D) Immune globulin - IM
88 http://hl7.org/fhir/sid/cvx   158 Influenza, split virus, quadrivalent, preservative Influenza, split virus, quadrivalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   159 influenza, unspecified Rho(D) - Unspecified formulation Rho(D) Unspecified formulation
16 http://hl7.org/fhir/sid/cvx   160 influenza, whole Influenza A monovalent (H5N1), ADJUVANTED-2013 Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
10 http://hl7.org/fhir/sid/cvx   161 IPV Influenza, injectable,quadrivalent, preservative free, pediatric Influenza, injectable,quadrivalent, preservative free, pediatric
134 http://hl7.org/fhir/sid/cvx   162 Japanese Encephalitis IM meningococcal B, recombinant meningococcal B vaccine, fully recombinant
39 http://hl7.org/fhir/sid/cvx   163 Japanese encephalitis SC meningococcal B, OMV meningococcal B vaccine, recombinant, OMV, adjuvanted
129 http://hl7.org/fhir/sid/cvx   164 Japanese Encephalitis, meningococcal B, unspecified meningococcal B, unspecified formulation
63 http://hl7.org/fhir/sid/cvx   165 Junin virus HPV9 Human Papillomavirus 9-valent vaccine
64 http://hl7.org/fhir/sid/cvx   166 leishmaniasis influenza, intradermal, quadrivalent, preservative free influenza, intradermal, quadrivalent, preservative free, injectable
65 http://hl7.org/fhir/sid/cvx   167 leprosy meningococcal, unknown serogroups meningococcal vaccine of unknown formulation and unknown serogroups
66 http://hl7.org/fhir/sid/cvx   168 Lyme disease Influenza, adjuvanted, trivalent, PF Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free
04 http://hl7.org/fhir/sid/cvx   169 M/R Hep A, live attenuated Hep A, live attenuated-IM
67 http://hl7.org/fhir/sid/cvx   170 malaria DTAP/IPV/HIB - non-US non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
05 http://hl7.org/fhir/sid/cvx   171 measles Influenza, MDCK, quadrivalent, PF Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free
68 http://hl7.org/fhir/sid/cvx   172 cholera, WC-rBS cholera, WC-rBS
http://hl7.org/fhir/sid/cvx   173 melanoma cholera, BivWC cholera, BivWC
191 http://hl7.org/fhir/sid/cvx   174 cholera, live attenuated cholera, live attenuated
http://hl7.org/fhir/sid/cvx   175 meningococcal A polysaccharide (non-US) Rabies - IM Diploid cell culture Human Rabies vaccine from human diploid cell culture
192 http://hl7.org/fhir/sid/cvx   176 Rabies - IM fibroblast culture Human rabies vaccine from Chicken fibroblast culture
http://hl7.org/fhir/sid/cvx   177 meningococcal AC polysaccharide (non-US) PCV10 pneumococcal conjugate vaccine, 10 valent
108 http://hl7.org/fhir/sid/cvx   178 OPV bivalent Non-US bivalent oral polio vaccine (types 1 and 3)
http://hl7.org/fhir/sid/cvx   179 meningococcal ACWY, OPV ,monovalent, unspecified Non-US monovalent oral polio vaccine, unspecified formulation
163 http://hl7.org/fhir/sid/cvx   180 meningococcal B, OMV tetanus immune globulin tetanus immune globulin
162 http://hl7.org/fhir/sid/cvx   181 anthrax immune globulin anthrax immune globulin
http://hl7.org/fhir/sid/cvx   182 meningococcal B, recombinant OPV, Unspecified Oral Polio Vaccine, Unspecified formulation
164 http://hl7.org/fhir/sid/cvx   183 Yellow fever vaccine live - alt Yellow fever vaccine live - alternative formulation for vaccine shortage
http://hl7.org/fhir/sid/cvx   184 meningococcal B, Yellow fever, unspecified Yellow fever vaccine, unspecified formulation
103 http://hl7.org/fhir/sid/cvx   185 meningococcal C conjugate Influenza, recombinant, quadrivalent, PF Influenza, recombinant, quadrivalent, injectable, preservative free
148 http://hl7.org/fhir/sid/cvx   186 Meningococcal C/Y-HIB PRP Influenza, MDCK, quadrivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative
147 http://hl7.org/fhir/sid/cvx   187 zoster recombinant zoster vaccine recombinant
http://hl7.org/fhir/sid/cvx   188 meningococcal MCV4, zoster, unspecified formulation zoster vaccine, unspecified formulation
136 http://hl7.org/fhir/sid/cvx   189 Meningococcal MCV4O HepB-CpG Hepatitis B vaccine (recombinant), CpG adjuvanted
114 http://hl7.org/fhir/sid/cvx   190 Typhoid conjugate vaccine (TCV) Typhoid conjugate vaccine (non-US)
http://hl7.org/fhir/sid/cvx   191 meningococcal MCV4P A polysaccharide (non-US) meningococcal A polysaccharide vaccine (non-US)
32 http://hl7.org/fhir/sid/cvx   192 meningococcal MPSV4 AC polysaccharide (non-US) meningococcal AC polysaccharide vaccine (non-US)
167 http://hl7.org/fhir/sid/cvx   193 meningococcal, unknown serogroups Hep A-Hep B, pediatric/adolescent hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
03 http://hl7.org/fhir/sid/cvx   194 MMR Influenza, Southern Hemisphere influenza, Southern Hemisphere, unspecified formulation
94 http://hl7.org/fhir/sid/cvx   195 MMRV DT, IPV adsorbed Diphtheria, Tetanus, Poliomyelitis adsorbed
07 http://hl7.org/fhir/sid/cvx   196 mumps Td, adsorbed, preservative free, adult use, Lf unspecified tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
127 http://hl7.org/fhir/sid/cvx   197 Novel influenza-H1N1-09 Influenza, high-dose, quadrivalent, PF Influenza, high-dose, split virus, quadrivalent, injectable, preservative free
128 http://hl7.org/fhir/sid/cvx   198 Novel Influenza-H1N1-09, all formulations DTP-hepB-Hib Pentavalent Non-US Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
125 http://hl7.org/fhir/sid/cvx   200 Novel Influenza-H1N1-09, nasal influenza, Southern Hemisphere, pediatric, preservative free influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
126 http://hl7.org/fhir/sid/cvx   201 Novel influenza-H1N1-09, preservative-free Influenza, Southern Hemisphere, quadrivalent, PF Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free
02 http://hl7.org/fhir/sid/cvx   202 OPV influenza, Southern Hemisphere, quadrivalent, with preservative influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
179 http://hl7.org/fhir/sid/cvx   203 OPV ,monovalent, unspecified meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free
178 http://hl7.org/fhir/sid/cvx   204 OPV bivalent Ebola Zaire vaccine, live, recombinant, 1mL dose Ebola Zaire vaccine, live, recombinant, 1mL dose
182 http://hl7.org/fhir/sid/cvx   205 OPV, Unspecified Influenza, adjuvanted, quadrivalent, PF Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free
69 http://hl7.org/fhir/sid/cvx   206 parainfluenza-3 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection
177 http://hl7.org/fhir/sid/cvx   207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
http://hl7.org/fhir/sid/cvx   208 PCV10 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
11 http://hl7.org/fhir/sid/cvx   210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
http://hl7.org/fhir/sid/cvx   211 pertussis COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
23 http://hl7.org/fhir/sid/cvx   212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
http://hl7.org/fhir/sid/cvx   213 plague SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
133 http://hl7.org/fhir/sid/cvx   214 Ebola, unspecified Ebola, unspecified
http://hl7.org/fhir/sid/cvx   215 Pneumococcal conjugate PCV 13 PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free
100 http://hl7.org/fhir/sid/cvx   216 pneumococcal Pneumococcal conjugate PCV 7 PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free
152 http://hl7.org/fhir/sid/cvx   217 Pneumococcal Conjugate, unspecified COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
33 http://hl7.org/fhir/sid/cvx   218 pneumococcal polysaccharide PPV23 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation
109 http://hl7.org/fhir/sid/cvx   219 pneumococcal, unspecified COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
89 http://hl7.org/fhir/sid/cvx   220 polio, unspecified formulation HepB recombinant, 3-antigen, Al(OH)3 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted
70 http://hl7.org/fhir/sid/cvx   221 Q fever COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
175 http://hl7.org/fhir/sid/cvx   222 Rabies - IM Diploid cell culture Tick-borne encephalitis, unspecified Tick-borne encephalitis vaccine, unspecified
176 http://hl7.org/fhir/sid/cvx   223 Rabies - IM fibroblast culture Tick-borne encephalitis, inactivated, PF, 0.25mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose
40 http://hl7.org/fhir/sid/cvx   224 rabies, intradermal injection Tick-borne encephalitis, inactivated, PF, 0.5mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose
18 http://hl7.org/fhir/sid/cvx   225 rabies, intramuscular injection COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
90 http://hl7.org/fhir/sid/cvx   226 rabies, unspecified formulation COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose
72 http://hl7.org/fhir/sid/cvx   227 rheumatic fever COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose
159 http://hl7.org/fhir/sid/cvx   228 Rho(D) - Unspecified formulation COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose
157 http://hl7.org/fhir/sid/cvx   229 Rho(D) -IG IM COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
156 http://hl7.org/fhir/sid/cvx   230 Rho(D)-IG COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose
73 http://hl7.org/fhir/sid/cvx   231 Rift Valley fever influenza, Southern Hemisphere, high-dose, quadrivalent influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free
34 http://hl7.org/fhir/sid/cvx   300 RIG COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
119 http://hl7.org/fhir/sid/cvx   301 rotavirus, monovalent COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
116 http://hl7.org/fhir/sid/cvx   302 rotavirus, pentavalent COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation
74 http://hl7.org/fhir/sid/cvx   303 rotavirus, tetravalent RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free
122 http://hl7.org/fhir/sid/cvx   304 rotavirus, Respiratory syncytial virus (RSV), unspecified Respiratory syncytial virus (RSV), unspecified formulation
71 http://hl7.org/fhir/sid/cvx   305 RSV-IGIV RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free
93 http://hl7.org/fhir/sid/cvx   306 RSV-MAb RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months
145 http://hl7.org/fhir/sid/cvx   307 RSV-MAb (new) RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months
06 http://hl7.org/fhir/sid/cvx   308 rubella COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose
38 http://hl7.org/fhir/sid/cvx   309 rubella/mumps COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
76 http://hl7.org/fhir/sid/cvx   310 Staphylococcus bacterio lysate COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
138 http://hl7.org/fhir/sid/cvx   311 Td (adult) COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
09 http://hl7.org/fhir/sid/cvx   312 Td (adult), 2 Lf tetanus toxoid, COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, adsorbed 50 mcg/0.5 mL dose
113 http://hl7.org/fhir/sid/cvx   313 Td (adult), COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 Lf tetanus toxoid, mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, adsorbed 5 mcg/0.5 mL dose
139 http://hl7.org/fhir/sid/cvx   314 Td(adult) Respiratory syncytial virus (RSV) vaccine, unspecified Respiratory syncytial virus (RSV) vaccine, unspecified formulation
115 http://hl7.org/fhir/sid/cvx   315 Tdap Respiratory syncytial virus (RSV) MAB, unspecified Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified
180 http://hl7.org/fhir/sid/cvx   316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Meningococcal polysaccharide (groups A, C, Y, W) tetanus immune globulin toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free
35 http://hl7.org/fhir/sid/cvx   317 tetanus toxoid, adsorbed Chikungunya live attenuated vaccine, 0.5 mL, PF Chikungunya, live attenuated vaccine, 0.5 mL, preservative free
142 http://hl7.org/fhir/sid/cvx   318 tetanus toxoid, not adsorbed Anthrax, post-exposure prophylaxis Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis
112 http://hl7.org/fhir/sid/cvx   319 tetanus toxoid, Anthrax vaccine, unspecified Anthrax vaccine, unspecified formulation
77 http://hl7.org/fhir/sid/cvx   320 tick-borne encephalitis Influenza, MDCK, trivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative
13 http://hl7.org/fhir/sid/cvx   321 TIG Influenza-avian, H5N8, monovalent, PF Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free
98 http://hl7.org/fhir/sid/cvx   322 Influenza-avian, H5N8, monovalent, preservative Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   323 TST, Influenza-avian, H5, unspecified formulation Influenza-avian, H5, unspecified formulation
95 http://hl7.org/fhir/sid/cvx   324 TST-OT tine test Poliovirus, inactivated, fractional-dose (fIPV) Poliovirus, inactivated, fractional-dose (fIPV)
96 http://hl7.org/fhir/sid/cvx   325 TST-PPD intradermal Vaccinia (smallpox, mpox), unspecified Vaccinia (smallpox, mpox), unspecified
97 http://hl7.org/fhir/sid/cvx   326 TST-PPD tine test RSV, mRNA, injectable, PF Respiratory syncytial virus (RSV), mRNA, injectable, preservative free
78 http://hl7.org/fhir/sid/cvx   327 tularemia vaccine Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free
190 http://hl7.org/fhir/sid/cvx   328 Typhoid conjugate vaccine (TCV) Meningococcal oligosaccharide (MenACWY), (MenB), PF Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free
25 http://hl7.org/fhir/sid/cvx   329 typhoid, oral Chikungunya, VLP, recombinant, 0.8 mL, PF Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free
41 http://hl7.org/fhir/sid/cvx   330 typhoid, parenteral Dengue fever, unspecified Dengue fever, unspecified formulation
53 http://hl7.org/fhir/sid/cvx   331 typhoid, parenteral, AKD (U.S. military) Influenza, Southern Hemisphere, trivalent, PF Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free
91 http://hl7.org/fhir/sid/cvx   332 typhoid, unspecified formulation RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ , (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free
101 http://hl7.org/fhir/sid/cvx   333 typhoid, ViCPs Influenza, live, trivalent, intranasal, self/caregiver admin, PF Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free
131 http://hl7.org/fhir/sid/cvx   500 typhus, historical COVID-19 Non-US Vaccine, Product Unknown SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown
75 http://hl7.org/fhir/sid/cvx   501 vaccinia (smallpox) COVID-19 IV Non-US Vaccine (QAZCOVID-IN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
105 http://hl7.org/fhir/sid/cvx   502 vaccinia (smallpox) diluted COVID-19 IV Non-US Vaccine (COVAXIN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
79 http://hl7.org/fhir/sid/cvx   503 vaccinia immune globulin COVID-19 LAV Non-US Vaccine (COVIVAC) SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
21 http://hl7.org/fhir/sid/cvx   504 varicella COVID-19 VVnr Non-US Vaccine (Sputnik Light) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
81 http://hl7.org/fhir/sid/cvx   505 VEE, inactivated COVID-19 VVnr Non-US Vaccine (Sputnik V) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
80 http://hl7.org/fhir/sid/cvx   506 VEE, live COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology
92 http://hl7.org/fhir/sid/cvx   507 VEE, unspecified formulation COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
36 http://hl7.org/fhir/sid/cvx   508 VZIG COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
117 http://hl7.org/fhir/sid/cvx   509 VZIG (IND) COVID-19 PS Non-US Vaccine (EpiVacCorona) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
37 http://hl7.org/fhir/sid/cvx   510 yellow fever COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
183 http://hl7.org/fhir/sid/cvx   511 Yellow fever vaccine - alt COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
184 http://hl7.org/fhir/sid/cvx   512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
http://hl7.org/fhir/sid/cvx   513 Yellow fever, unspecified formulation SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)
121 http://hl7.org/fhir/sid/cvx   514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
http://hl7.org/fhir/sid/cvx   515 zoster live SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
187 http://hl7.org/fhir/sid/cvx   516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
http://hl7.org/fhir/sid/cvx   517 zoster recombinant SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
188 http://hl7.org/fhir/sid/cvx   518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
http://hl7.org/fhir/sid/cvx   519 zoster, unspecified formulation COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
998 http://hl7.org/fhir/sid/cvx   520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
http://hl7.org/fhir/sid/cvx   521 no COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK SARS-COV-2 (COVID-19) vaccine administered SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
99 http://hl7.org/fhir/sid/cvx   801 RESERVED - do not use AS03 Adjuvant AS03 Adjuvant
999 http://hl7.org/fhir/sid/cvx   998 no vaccine administered no vaccine administered
http://hl7.org/fhir/sid/cvx   999 unknown unknown vaccine or immune globulin
AGRPAL urn:oid:1.2.36.1.2001.1005.17   AGRPAL Agrippal
AVAXM urn:oid:1.2.36.1.2001.1005.17   AVAXM Avaxim
BCG urn:oid:1.2.36.1.2001.1005.17   BCG BCG
CDT urn:oid:1.2.36.1.2001.1005.17   CDT CDT
CMX urn:oid:1.2.36.1.2001.1005.17   CMX COMVAX
DTP urn:oid:1.2.36.1.2001.1005.17   DTP Triple Antigen
DTPA urn:oid:1.2.36.1.2001.1005.17   DTPA DTPa
ENGP urn:oid:1.2.36.1.2001.1005.17   ENGP Engerix B
FLRIX urn:oid:1.2.36.1.2001.1005.17   FLRIX Fluarix
FLUVAX urn:oid:1.2.36.1.2001.1005.17   FLUVAX Fluvax
FLVRN urn:oid:1.2.36.1.2001.1005.17   FLVRN Fluvirin
FVXJNR urn:oid:1.2.36.1.2001.1005.17   FVXJNR Fluvax Junior
GNDIP urn:oid:1.2.36.1.2001.1005.17   GNDIP Diphtheria
GNFLU urn:oid:1.2.36.1.2001.1005.17   GNFLU Influenza
GNHEP urn:oid:1.2.36.1.2001.1005.17   GNHEP Hepatitis B
GNHIB urn:oid:1.2.36.1.2001.1005.17   GNHIB HIB
GNHPA urn:oid:1.2.36.1.2001.1005.17   GNHPA Hepatitis A
GNJEN urn:oid:1.2.36.1.2001.1005.17   GNJEN Japanese Encephalitis
GNMEA urn:oid:1.2.36.1.2001.1005.17   GNMEA Measles
GNMEN urn:oid:1.2.36.1.2001.1005.17   GNMEN Meningococcal C
GNMUM urn:oid:1.2.36.1.2001.1005.17   GNMUM Mumps
GNPNE urn:oid:1.2.36.1.2001.1005.17   GNPNE Pneumococcal
GNPOL urn:oid:1.2.36.1.2001.1005.17   GNPOL Polio
GNROX urn:oid:1.2.36.1.2001.1005.17   GNROX Rotavirus
GNRUB urn:oid:1.2.36.1.2001.1005.17   GNRUB Rubella
GNTET urn:oid:1.2.36.1.2001.1005.17   GNTET Tetanus
GNVAR urn:oid:1.2.36.1.2001.1005.17   GNVAR Varicella
HATWNJ urn:oid:1.2.36.1.2001.1005.17   HATWNJ Twinrix Junior
HAVAQ urn:oid:1.2.36.1.2001.1005.17   HAVAQ Vaqta Paed/Adol
HAVJ urn:oid:1.2.36.1.2001.1005.17   HAVJ Havrix Junior
HBOC urn:oid:1.2.36.1.2001.1005.17   HBOC HibTITER
HBV urn:oid:1.2.36.1.2001.1005.17   HBV HBV
HBVP urn:oid:1.2.36.1.2001.1005.17   HBVP HBVAX II
HBX urn:oid:1.2.36.1.2001.1005.17   HBX Hiberix
IFHX urn:oid:1.2.36.1.2001.1005.17   IFHX Infanrix Hexa
IFIP urn:oid:1.2.36.1.2001.1005.17   IFIP Infanrix-IPV
IFPA urn:oid:1.2.36.1.2001.1005.17   IFPA Infanrix Penta
IFX urn:oid:1.2.36.1.2001.1005.17   IFX Infanrix
IFXB urn:oid:1.2.36.1.2001.1005.17   IFXB InfanrixHepB
INFLUV urn:oid:1.2.36.1.2001.1005.17   INFLUV Influvac
IPV urn:oid:1.2.36.1.2001.1005.17   IPV IPOL
JEVAX urn:oid:1.2.36.1.2001.1005.17   JEVAX JE-VAX
MENJUG urn:oid:1.2.36.1.2001.1005.17   MENJUG Menjugate
MENTEC urn:oid:1.2.36.1.2001.1005.17   MENTEC Meningitec
MENUME urn:oid:1.2.36.1.2001.1005.17   MENUME Menomune
MENVAX urn:oid:1.2.36.1.2001.1005.17   MENVAX Mencevax ACWY
MMR urn:oid:1.2.36.1.2001.1005.17   MMR MMR
MMRCSL urn:oid:1.2.36.1.2001.1005.17   MMRCSL MMR II
MMRSKB urn:oid:1.2.36.1.2001.1005.17   MMRSKB Priorix
MNTRX urn:oid:1.2.36.1.2001.1005.17   MNTRX Menitorix
NEISVC urn:oid:1.2.36.1.2001.1005.17   NEISVC NeisVac-C
OPV urn:oid:1.2.36.1.2001.1005.17   OPV Polio
P urn:oid:1.2.36.1.2001.1005.17   P Pertussis
PANVAX urn:oid:1.2.36.1.2001.1005.17   PANVAX Panvax
PDCL urn:oid:1.2.36.1.2001.1005.17   PDCL Pediacel
PLCL urn:oid:1.2.36.1.2001.1005.17   PLCL Poliacel
PNEUMO urn:oid:1.2.36.1.2001.1005.17   PNEUMO Pneumovax
PRPD urn:oid:1.2.36.1.2001.1005.17   PRPD ProHIBit
PROQAD urn:oid:1.2.36.1.2001.1005.17   PROQAD ProQuad
PRPOMP urn:oid:1.2.36.1.2001.1005.17   PRPOMP PedvaxHIB
PRPT urn:oid:1.2.36.1.2001.1005.17   PRPT ActHIB
PRVNR urn:oid:1.2.36.1.2001.1005.17   PRVNR Prevenar 7
PRVTH urn:oid:1.2.36.1.2001.1005.17   PRVTH Prevenar 13
PRXTEX urn:oid:1.2.36.1.2001.1005.17   PRXTEX Priorix-Tetra
QDCL urn:oid:1.2.36.1.2001.1005.17   QDCL Quadracel
ROTRIX urn:oid:1.2.36.1.2001.1005.17   ROTRIX Rotarix
ROTTEQ urn:oid:1.2.36.1.2001.1005.17   ROTTEQ Rotateq
SYNFLX urn:oid:1.2.36.1.2001.1005.17   SYNFLX Synflorix
TCL urn:oid:1.2.36.1.2001.1005.17   TCL Tripacel
VAXGRP urn:oid:1.2.36.1.2001.1005.17   VAXGRP Vaxigrip
VGRJNR urn:oid:1.2.36.1.2001.1005.17   VGRJNR Vaxigrip Junior
VLRIX urn:oid:1.2.36.1.2001.1005.17   VLRIX Varilrix
VRVAX urn:oid:1.2.36.1.2001.1005.17   VRVAX Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code